论文检索

精准精神健康：通过数据整合预测抑郁症的异质性处理效应AI 解读

When treating depression, clinicians are interested in determining the optimal treatment for a given patient, which is challenging given the amount of treatments available. To advance individualized treatment allocation, integrating data across multiple randomized controlled trials (RCTs) can enhance our understanding of treatment effect heterogeneity by increasing available information. However, extending these inferences to individuals outside of the original RCTs remains…

用平衡权重整合随机试验与外部对照数据：估计目标与估计量比较AI 解读

Randomized controlled trials (RCTs) face inherent limitations, such as ethical or resource constraints, which lead to a limited number of study participants. To address these limitations, recent research endeavors have sought to incorporate external control (EC) data, such as historical trial data or real-world data, with RCT data in treatment effect evaluation. This integration introduces unique questions regarding target population specification, causal estimand, and…

以校准的 g 先验混合层级模型估计荟萃分析中的处理效应调节AI 解读

Assessing treatment effect moderation is critical in biomedical research and many other fields, as it guides personalized intervention strategies to improve participant's outcomes. Individual participant-level data meta-analysis (IPD-MA) offers a robust framework for such assessments by leveraging data from multiple trials. However, its performance is often compromised by challenges such as high between-trial variability. Traditional Bayesian shrinkage methods have gained…

带阈值识别的生物标志物引导自适应富集生存试验设计AI 解读

Biomarker-guided designs are increasingly used to evaluate personalized treatments based on patients' biomarker status in Phase II and III clinical trials. With adaptive enrichment, these designs can improve the efficiency of evaluating the treatment effect in biomarker-positive patients by increasing their proportion in the randomized trial. While time-to-event outcomes are often used as the primary endpoint to measure treatment effects for a new therapy in severe diseases…

多区域临床试验中基于限制平均生存时间的处理效应及区域修饰因素推断AI 解读

Multi-regional clinical trials (MRCTs) play an increasingly crucial role in global pharmaceutical development by expediting data gathering and regulatory approval across diverse patient populations. However, differences in recruitment practices and regional demographics often lead to variations in study participant characteristics, potentially biasing treatment effect estimates and undermining treatment effect consistency assessment across regions. To address this challenge,…

合并多项随机试验估计异质性处理效应的方法比较AI 解读

Individualized treatment decisions can improve health outcomes, but using data to make these decisions in a reliable, precise, and generalizable way is challenging with a single dataset. Leveraging multiple randomized controlled trials allows for the combination of datasets with unconfounded treatment assignment to better estimate heterogeneous treatment effects. This paper discusses several non-parametric approaches for estimating heterogeneous treatment effects using data…

利用个体数据与限制平均生存时间回归开展生存结局网络荟萃分析AI 解读

Restricted mean survival time (RMST) models have gained popularity when analyzing time-to-event outcomes because RMST models offer more straightforward interpretations of treatment effects with fewer assumptions than hazard ratios commonly estimated from Cox models. However, few network meta-analysis (NMA) methods have been developed using RMST. In this paper, we propose advanced RMST NMA models when individual participant data are available. Our models allow us to study…

整合试验与非实验数据研究处理效应异质性的方法AI 解读

Estimating treatment effects conditional on observed covariates can improve the ability to tailor treatments to particular individuals. Doing so effectively requires dealing with potential confounding, and also enough data to adequately estimate effect moderation. A recent influx of work has looked into estimating treatment effect heterogeneity using data from multiple randomized controlled trials and/or observational datasets. With many new methods available for assessing…